Research Topics
Genomes and Genes
| Amanda B SpurdleSummaryAffiliation: Queensland Institute of Medical Research Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty yearsA B Spurdle
Cancer Unit, Joint Experimental Oncology Programme, Queensland Institute of Medical Research, and The University of Queensland, Brisbane, Australia
J Natl Cancer Inst 91:961-6. 1999..We conducted a population-based, case-control-family study to determine whether androgen receptor (AR) exon 1 polymorphic CAG repeat length (CAGn) was a risk factor for early-onset breast cancer in the Australian population...
The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancerAmanda B Spurdle
Cancer and Cell Biology Division, The Queensland Institute of Medical Research, Herston, PO Royal Brisbane Hospital, Queensland 4029, Australia
Gynecol Oncol 90:145-9. 2003..We assessed the association of the prohibitin 3' untranslated region polymorphism with risk of ovarian cancer in the Australian population by case-control comparison...
Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian womenAmanda B Spurdle
Cancer and Cell Biology Division, Joint Experimental Oncology Programme, Queensland Institute of Medical Research, and University of Queensland, Brisbane, Australia
Lancet 360:925-6. 2002..96, 95% CI 0.80-1.16; p=0.7), or in subgroups defined by age or family history, or both. Hence, our results do not lend support to the hypothesis that this polymorphism contributes to risk of breast cancer...
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancerAmanda B Spurdle
Cancer and Cell Biology Division, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research and The University of Queensland, Brisbane, Australia
Pharmacogenetics 12:355-66. 2002....
The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian womenAmanda B Spurdle
Oncology Division, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research, and The University of Queensland, Brisbane, 4029, Australia
Cancer Epidemiol Biomarkers Prev 11:439-43. 2002..However, despite its considerable size, our study cannot exclude a small reduced or increased risk associated with the T allele, especially the rare TT genotype...
The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 yearsAmanda B Spurdle
Oncology Division, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research and The University of Queensland, Brisbane, 4029 Australia
Cancer Epidemiol Biomarkers Prev 11:413-6. 2002..The BRCA2 N372H polymorphism appears to be associated with a modest recessively inherited risk of breast cancer in Australian women. This result is consistent with the findings for Northern European women...
No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancerA B Spurdle
Oncology Division, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Herston, Queensland, Australia
Carcinogenesis 22:717-21. 2001....
Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtypeA B Spurdle
Cancer Unit, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research, Queensland 4029, Australia
Carcinogenesis 22:67-72. 2001..04 (1.01-4.09), P = 0.05], suggesting that deletion of GSTM1 may increase the risk of ovarian cancer of these histological subtypes specifically. This marginally significant finding will require verification by independent studies...
CYP17 promoter polymorphism and breast cancer in Australian women under age forty yearsA B Spurdle
Cancer Unit, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research, and The University of Queensland, Brisbane, Australia
J Natl Cancer Inst 92:1674-81. 2000..Because steroid hormone exposure is known to influence breast cancer risk, we conducted a population-based, case-control-family study to assess the relationship between the CYP17 promoter polymorphism and early-onset breast cancer...
Androgen receptor exon 1 CAG repeat length and risk of ovarian cancerA B Spurdle
Cancer Unit, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research and The University of Queensland, Brisbane, Queensland, Australia
Int J Cancer 87:637-43. 2000..Our data provide no evidence for an association between ovarian cancer risk and the genotype defined by the AR exon 1 CAG(n) polymorphism, although we cannot exclude small effects, or threshold effects in a small subgroup...
Exploring the link between MORF4L1 and risk of breast cancerGriselda Martrat
Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
Breast Cancer Res 13:R40. 2011..To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens...
The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle
Queensland Institute of Medical Research, Brisbane, Australia
Breast Cancer Res 7:R176-83. 2005..Women with germline BRCA1 mutations who carry at least one AR allele with 28 or more repeats have been reported to have an earlier age at onset of breast cancer...
No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancerAmanda B Spurdle
Cancer and Cell Biology Division, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Queensland, Australia
Breast Cancer Res 4:R15. 2002..We investigate the breast cancer risk associated with these two nonconservative amino acid substitution variants using a large Australian population-based case-control study...
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family StudyJiun Horng Chang
Centre for Genetic Epidemiology, The University of Melbourne, Victoria, Australia
Breast Cancer Res 7:R513-21. 2005..We attempted to replicate the findings of studies assessing such interactions with the -34T-->C polymorphism...
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle
Division of Genetics and Population Health, Queensland Institute of Medical Research, 300 Herston Rd, Herston 4006, Australia
Breast Cancer Res Treat 122:281-5. 2010..These results support the need for replication studies to confirm or refute hypothesis-generating studies...
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1Felicity Lose
Cancer and Cell Biology Division, Queensland Institute of Medical Research, Herston, Brisbane, Queensland, Australia
J Natl Cancer Inst 100:1519-29. 2008....
A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer riskAmanda B Spurdle
Cancer and Cell Biology Division, The Queensland Institute of Medical Research and The University of Queensland, Brisbane, Queensland, Australia
Cancer Epidemiol Biomarkers Prev 16:769-74. 2007....
Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab InvestigatorsAmanda B Spurdle
Queensland Institute of Medical Research, c o Royal Brisbane Hospital Post Office, Herston, Queensland 4029, Australia
J Clin Oncol 26:1657-63. 2008..We assessed the value of tumor immunohistochemical markers in conjunction with genetic and evolutionary approaches for investigating the clinical significance of unclassified variants...
Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundaryPhillip J Whiley
Queensland Institute of Medical Research, Brisbane, Australia
Hum Mutat 32:678-87. 2011....
The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysisSharon E Johnatty
Cancer and Cell Biology, Queensland Institute of Medical Research, Brisbane, QLD, Australia
Breast Cancer Res Treat 115:145-50. 2009..Segregation analysis of 14 kConFab variant-carrying families containing 157 genotyped individuals provided no evidence of segregation with disease. We conclude that the BARD1 Cys557Ser variant is not associated with breast cancer risk...
Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survivalJyotsna Batra
School of Life Sciences, Hormone Dependent Cancer Research Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia
Int J Gynecol Cancer 20:529-36. 2010..We aimed to identify whether KLK10 overexpression could be attributed to genetic variants, in particular, in hormone response elements or transcription factor binding sites...
BCoR-L1 variation and breast cancerFelicity Lose
Cancer and Cell Biology Division, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Queensland, Australia, 4006
Breast Cancer Res 9:R54. 2007..BCoR-L1 is located on the X chromosome and is subject to X inactivation...
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriersAmanda B Spurdle
QueenslanInstitute for Medical Research, Brisbane, Australia
Cancer Epidemiol Biomarkers Prev 20:1032-8. 2011..Inherited BRCA1 and BRCA2 (BRCA1/2) mutations confer elevated breast cancer risk. Knowledge of factors that can improve breast cancer risk assessment in BRCA1/2 mutation carriers may improve personalized cancer prevention strategies...
Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriersLogan C Walker
Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, QLD, Australia
Breast Cancer Res Treat 112:229-36. 2008..Similar approaches may be used to identify genes and underlying genetic risk factors that interact with exogenous stimulants to cause or modify any disease, without a priori knowledge of the pathways involved...
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation setJonathan Beesley
Queensland Institute of Medical Research, Herston, Queensland, Australia
Cancer Epidemiol Biomarkers Prev 16:2557-65. 2007..Further analyses of SNPs in this gene are therefore warranted to determine whether SRD5A2 plays a role in ovarian cancer predisposition...
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer riskAmanda B Spurdle
Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
J Med Genet 49:525-32. 2012..5096G>A p.Arg1699Gln in the BRCA1 transcriptional transactivation domain demonstrated equivocal results from a series of functional assays, and proposed that this variant may confer low to moderate risk of cancer...
Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicityLogan C Walker
Queensland Institute of Medical Research, Brisbane, Australia
Hum Mutat 31:E1484-505. 2010..Arg3052Trp), supporting experimentally derived evidence. These findings highlight the need for improved bioinformatic prediction of splicing aberrations and to refine multifactorial likelihood models used to assess clinical significance...
Double-strand break repair gene polymorphisms and risk of breast or ovarian cancerPenelope M Webb
Population and Clinical Sciences Division, Queensland Institute of Medical Research and University of Queensland, Brisbane, Queensland, Australia
Cancer Epidemiol Biomarkers Prev 14:319-23. 2005....
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty
Cancer and Cell Biology, Queensland Institute of Medical Research, c o Royal Brisbane Hospital Post Office, Herston, Brisbane, QLD 4029, Australia
Breast Cancer Res Treat 117:371-9. 2009..93, 95% CI 0.80-1.07). We conclude that there is no evidence that either GATA3 rs570613, or any variant in strong linkage disequilibrium with it, is associated with breast cancer risk in women...
Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studiesSharon E Johnatty
Cancer and Cell Biology, Queensland Institute of Medical Research, c o Royal Brisbane Hospital Post Office, Herston, Brisbane, QLD, 4029, Australia
Breast Cancer Res Treat 109:91-9. 2008....
Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genesChristina M Nagle
Cancer and Population Studies, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Queensland 4029, Australia
Cancer Lett 251:96-104. 2007..However, given the marginal significance of these associations and the large number of tests performed, independent replication will be necessary to validate these novel findings...
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?Paul K Lovelock
Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Herston Road, Queensland 4029, Australia
Breast Cancer Res 9:R82. 2007....
Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS dataJyotsna Batra
Australian Prostate Cancer Research centre Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia
PLoS ONE 6:e26527. 2011..Kallikrein 15 (KLK15)/Prostinogen is a plausible candidate for prostate cancer susceptibility. Elevated KLK15 expression has been reported in prostate cancer and it has been described as an unfavorable prognostic marker for the disease...
Dominant negative ATM mutations in breast cancer familiesGeorgia Chenevix-Trench
Queensland Institute of Medical Research, Brisbane, Australia
J Natl Cancer Inst 94:205-15. 2002..We examined these two ATM mutations in a population-based, case-control series of breast cancer families and multiple-case breast cancer families...
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle
The Queensland Institute of Medical Research, Brisbane, Australia
Cancer Epidemiol Biomarkers Prev 15:76-9. 2006..Given the large sample size, with more than adequate power to detect previously reported effects, we conclude that the AIB1 glutamine repeat does not substantially modify risk of breast cancer in BRCA1 and BRCA2 mutation carriers...
Rare variants in the ATM gene and risk of breast cancerDavid E Goldgar
Department of Dermatology, University of Utah School of Medicine, 30 N 1900 E, Salt Lake City, UT 84132 2101, USA
Breast Cancer Res 13:R73. 2011..However, the magnitude of risk and the subset of variants that are pathogenic for breast cancer remain unresolved...
Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patientsLogan C Walker
Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane, Australia
PLoS Genet 6:e1000850. 2010....
Bayes analysis provides evidence of pathogenicity for the BRCA1 c.135-1G>T (IVS3-1) and BRCA2 c.7977-1G>C (IVS17-1) variants displaying in vitro splicing results of equivocal clinical significanceAmanda B Spurdle
Queensland Institute of Medical Research, Brisbane, Australia
Hum Mutat 31:E1141-5. 2010..Multifactorial likelihood analysis indicates that the BRCA1 c.135-1G>T and BRCA2 c.7977-1G>C variants are disease-associated mutations which should be managed clinically in the same fashion as classical truncating mutations...
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"Sharon E Johnatty
Queensland Institute of Medical Research, Brisbane, Australia
PLoS Genet 6:e1001016. 2010..ORper-allele 1.14 (1.04-1.24) p=0.003]. Our study adds to the growing evidence that, like the 8q24 locus, the telomerase reverse transcriptase locus at 5p15.33, is a general cancer susceptibility locus...
Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive FamiliesDavid L Duffy
Genetics and Population Health Division, Queensland Institute of Medical Research, Herston, Queensland, Australia
Twin Res Hum Genet 14:111-8. 2011..Early onset EC in carriers without tamoxifen use suggests that further study is required to assess association of modest EC risk with BRCA1/2 mutation status alone...
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold
Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane, Australia
Hum Mutat 30:757-70. 2009..Classification of mismatch repair gene variants is assisted by a comprehensive approach that includes in vitro, tumor pathology, clinical, and evolutionary conservation data...
Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancerAaron G Lewis
Department of Cancer Genetics, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
Breast Cancer Res 7:R1005-16. 2005..We hypothesized that germline mutations in FANCD2, BRIP1/BACH1, LMO4 and SFN may account for some of the unexplained multiple-case breast cancer families...
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle
Queensland Institute of Medical Research, Brisbane, Australia
Breast Cancer Res Treat 115:307-13. 2009..99-2.18; P = 0.06 for BRCA2). The 95% confidence intervals for per allele risk estimates excluded a twofold risk, indicating that common CDKN1B polymorphisms do not markedly modify breast cancer risk among BRCA1 or BRCA2 carriers...
The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia)Sharon E Johnatty
Queensland Institute of Medical Research, Brisbane, P O Royal Brisbane Hospital, Herston, QLD 4029, Australia
Gynecol Oncol 107:388-91. 2007..We assessed the MnSOD Val9Ala polymorphism and its interaction with dietary antioxidant intake in ovarian cancer risk and survival...
The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressivenessFelicity Lose
Molecular Cancer Epidemiology Group, Genetics and Population Health Division, Queensland Institute of Medical Research, Herston, Brisbane, Australia
Biol Chem 393:403-12. 2012..Gln33Arg substitution in the KLK14 signal peptide region. Our findings provide further support for KLK14 as a marker of prognosis in prostate cancer...
ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesAmanda B Spurdle
Queensland Institute of Medical Research, Brisbane, Australia
Hum Mutat 33:2-7. 2012..It is envisaged that the research and clinical application of models developed by ENIGMA will be relevant to the interpretation of sequence variants in other disease genes...
BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expressionNic Waddell
Queensland Institute of Medical Research, Brisbane, Australia
PLoS Genet 4:e1000080. 2008..This study indicates that mutation effect, and presence of rare variants possibly associated with a low risk of cancer, must be considered in the development of array-based assays of variant pathogenicity...
Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registryMichael D Walsh
Familial Cancer Laboratory, I Floor, Bancroft Centre, Queensland Institute of Medical Research, Herston Road, Herston, Queensland 4006, Australia
Clin Cancer Res 16:2214-24. 2010..The recognition of breast cancer as a spectrum tumor in Lynch syndrome remains controversial. The aim of this study was to explore features of breast cancers arising in Lynch syndrome families...
Prioritizing candidate genetic modifiers of BRCA1 and BRCA2 using a combinatorial analysis of global expression and polymorphism association studies of breast cancerLogan C Walker
PO Royal Brisbane Hospital, Queensland Institute of Medical Research, Herston, QLD, Australia
Methods Mol Biol 653:23-34. 2010....
Genetic association of the KLK4 locus with risk of prostate cancerFelicity Lose
Molecular Cancer Epidemiology Group, Genetics and Population Health Division, Queensland Institute of Medical Research, 300 Herston Rd, Herston, Brisbane, Queensland, Australia
PLoS ONE 7:e44520. 2012..98). Our findings provide suggestive evidence of a role for genetic variation in the KLK4 locus in prostate cancer predisposition...
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker
Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Australia
Breast Cancer Res 12:R102. 2010..In this study, we evaluated 24 SNPs tagged to 14 candidate genes derived through a novel approach that analysed gene expression differences to prioritise candidate modifier genes for association studies...
Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variabilityPaul K Lovelock
School of Molecular and Microbial Sciences, University of Queensland, Brisbane, Australia
Breast Cancer Res Treat 104:257-66. 2007..We assessed the ability of several assays of LCLs to distinguish carriers of germline BRCA1 and BRCA2 gene mutations from mutation-negative controls to determine their utility for use in a diagnostic setting...
The role of glutathione-S-transferase polymorphisms in ovarian cancer survivalChristina M Nagle
Cancer and Population Studies Division, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, QLD 4029, Australia
Eur J Cancer 43:283-90. 2007..02). The results of this study, the largest to date, are consistent with a number of previous smaller studies which have also observed that reduced GST function was associated with better survival outcomes in patients with ovarian cancer...
Vascular endothelial growth factor gene polymorphisms and ovarian cancer survivalFelicity Lose
Molecular Cancer Epidemiology, Queensland Institute of Medical Research, P O Royal Brisbane Hospital, Herston, Brisbane, QLD 4029, Australia
Gynecol Oncol 119:479-83. 2010..We sought to evaluate the effect of polymorphisms in the VEGF (Vascular Endothelial Growth Factor) gene on overall survival in ovarian cancer patients...
Mutation analysis of five candidate genes in familial breast cancerAnna Marsh
Cancer and Cell Biology, Queensland Institute of Medical Research, c o RBH Post Office, Herston, Brisbane, QLD, 4029, Australia
Breast Cancer Res Treat 105:377-89. 2007..Although we identified many novel variants, we found no evidence that highly penetrant germline mutations in these five genes contribute to familial breast cancer susceptibility...
Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significanceGeorgia Chenevix-Trench
Queensland Institute of Medical Research, Brisbane, Australia
Cancer Res 66:2019-27. 2006..Five of these neutral variants were also found in at least 1 of 180 healthy controls, suggesting that screening a large number of appropriate controls might be a useful adjunct to other methods for evaluation of unclassified variants...
Variation in the RAD51 gene and familial breast cancerFelicity Lose
Cancer and Cell Biology Division, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
Breast Cancer Res 8:R26. 2006..Few studies have investigated the role of coding region variation in the RAD51 gene in familial breast cancer, with only one coding region variant--exon 6 c.449G>A (p.R150Q)--reported to date...
Genome-wide association study identifies a common variant associated with risk of endometrial cancerAmanda B Spurdle
Division of Genetics and Population Health, Queensland Institute of Medical Research, Brisbane, Queensland, Australia
Nat Genet 43:451-4. 2011..We identified an endometrial cancer susceptibility locus close to HNF1B at 17q12 (rs4430796, P = 7.1 × 10(-10)) that is also associated with risk of prostate cancer and is inversely associated with risk of type 2 diabetes...
Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortiumSharon E Johnatty
Queensland Institute of Medical Research, Brisbane, Queensland, Australia
Twin Res Hum Genet 12:269-75. 2009..Overall genetic variation in FGF2 does not appear to play a role in susceptibility to ovarian cancer...
Mutation deep within an intron of MSH2 causes Lynch syndromeMark Clendenning
Familial Cancer Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, QLD, Australia
Fam Cancer 10:297-301. 2011....
No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian womenJonathan Beesley
Genetics and Population Health Division, Queensland Institute of Medical Research, Herston, 4006, Brisbane, Australia
Breast Cancer Res Treat 126:235-9. 2011..We therefore analysed the frequency of the functional SNP in 1342 cases and 2256 controls from two breast cancer studies of Caucasian women but found no evidence for an association with breast cancer risk...
Progesterone receptor gene variants and risk of endometrial cancerTracy A O'Mara
Genetics and Population Health Division, Queensland Institute of Medical Research, Herston, Brisbane, Queensland 4006, Australia
Carcinogenesis 32:331-5. 2011..Replication studies will be required to refine the risk estimate and to establish if this, or a correlated SNP, is the underlying causative variant...
Possible genetic predisposition to lymphedema after breast cancerBeth Newman
Institute of Health and Biomedical Innovation and School of Public Health, Queensland University of Technology, Brisbane, Australia
Lymphat Res Biol 10:2-13. 2012..Recent advances in the molecular biology underlying development of the lymphatic system and related congenital disorders implicate a number of potential candidate genes to explore in relation to secondary lymphedema...
A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survivalJyotsna Batra
Australian Prostate Cancer Research centre Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Queensland 4059, Australia
BMC Cancer 11:119. 2011..Our aim was to analyse the KLK15 gene for putative functional single nucleotide polymorphisms (SNPs) and assess the association of these and KLK15 HapMap tag SNPs with ovarian cancer survival...
Use of talcum powder and endometrial cancer riskAnnette S Neill
Genetics and Population Health Division, Queensland Institute of Medical Research, Herston, Brisbane, Australia
Cancer Causes Control 23:513-9. 2012..We sought to confirm this association using data from the Australian National Endometrial Cancer Study (ANECS)...
RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian womenLivia Kelemen
Cancer and Cell Biology Division, Queensland Institute of Medical Research and the University of Queensland, Brisbane, Australia
Cancer Lett 218:191-7. 2005..6 and 4% were observed among cases and controls, respectively. The risk estimate was 0.55 (95%CI 0.24-1.24), suggesting that the RAD52 Y415X polymorphism is not associated with epithelial ovarian cancer in Australian women...
Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donorsAlice Che Ha Chen
The University of Queensland, Diamantina Institute for Cancer, Immunology and Metabolic Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, QLD, Australia
J Med Virol 81:1792-6. 2009..HPV was also isolated in the B cells, dendritic cells, NK cells, and neutrophils. To conclude, HPV present in PBMCs could represent a reservoir of virus and a potential new route of transmission...
Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control studyEmily J Fearnley
School of Population Health, The University of Queensland, Herston Road, Herston, QLD 4006, Australia
Cancer Causes Control 21:2303-8. 2010..Our aim was to assess the associations between PCOS, PCOS symptoms, and risk of endometrial cancer in women aged less than 50 years...
Clinical relevance of rare germline sequence variants in cancer genes: evolution and application of classification modelsAmanda B Spurdle
Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane, Australia
Curr Opin Genet Dev 20:315-23. 2010..However there is need to be cautious of the noted limitations and caveats of the current model, some of which may be exacerbated by differences in ascertainment and biological pathways to disease for different cancer syndromes...
PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibilityJohn Lai
Cluster for Molecular Biotechnology, School of Life Sciences and Science Research Centre, Queensland University of Technology, Victoria Park Road, Kelvin Grove, Brisbane, QLD 4059, Australia
Carcinogenesis 28:1032-9. 2007....
Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphismsChristopher Pettigrew
School of Molecular and Microbial Sciences, The University of Queensland, St, Lucia, Queensland, Australia
Breast Cancer Res 7:R929-39. 2005..Although predicting the effects of changes in consensus 5' and 3' splice sites near intron:exon boundaries is relatively straightforward, predicting the possible effects of changes in exonic splicing enhancers (ESEs) remains a challenge...
ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapySharon E Johnatty
Queensland Institute of Medical Research, Brisbane, Queensland, Australia
Clin Cancer Res 14:5594-601. 2008..Although the functional consequences of ABCB1 polymorphisms have been the subject of numerous studies, few have assessed the association with clinical outcome...
